Related Articles
HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.
Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines
Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma